{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"acquired-generalized-lipodystrophy","columns":[{"gene":"","key":"population-3ed1f8a000d5d8991015","label":"Acquired generalized lipodystrophy","mondoId":"MONDO:0019193","onsetQualifier":null,"originColumnKey":"MONDO:0019193/ORPHA:79086","originalViews":[{"key":"MONDO:0019193/ORPHA:79086","label":"Acquired generalized lipodystrophy","scopeLabel":"ORPHA:79086","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0928c654a979a6875d8f3e1556f89a1a8e2b4b6370343ee6812ba88b51592786","0a97ce97fc2b50c4b7e70615d1f4f8ed15e215ccdc1ed0db938aaca271930d28","0dfbeb03c6b16df44666c7cb5af727fc3ab44693f90dcb9a9e988a9bd28f2bc1","0e8dc948e7d635e9ca37b79c7a23081a65db67c4399945985bb6951a5c6e56b7","1935c6cb733a8ab6b3a16bfcd4541a9335c54e53ebdd2f197805a7abd4a5a312","30024c96a2c3c16608d0337e5549093146826a5b92e685ddd07455f69b31a2fe","4753473b68d328c835c966fc40957564ad005d5b8e7a13dcbfb3048167072ebb","4811325d6fc584141fa12679ec7b72273ded7cc294adf3bd3a79b9e9b0364170","5c4e29e9de9619eb3ff85b8eca777c8d63c9abdb4b1a396ae283ed6d18558a1c","5ec7be299a25c5031c9da719591999420ba8f41208c18885c439ce4b541f358c","63503c966187ef073a282efe75f440f52b006d62f89fdba59d492544b2003123","6fcc62aad29f45ff5c7a21b25047c54f7bc169a4094974c02d7f9d4bd6c2e97a","7ff1183729d2a3114bd5e943af5c60984679a952ae3d6a494926b3c733cbce4d","809e359603b6e5d4894b7662bd5bdace0d65151456b9ecffcf17fd6443ccf3b2","894afe34c81524427588d9d3bdc9072ebca4b335c8b74d22d7695e3104494171","9da8ea84d8eba5670a5e29f76a1a154dca037458871d1d37cee6930f8a557e66","a4d929869b0aa27bc53fbb19ab4e2fb11b0a488bfd470a0bf9429e3b6270083e","a5535c58b8c517467712c1fcf8807cb72fe3c435c712ccac9d5365af1d0e5199","b22ac21dc15feb43c9e8ba378a25065fa4b15967b1b736790a429cdf7d8288b2","b5c74f3b11bf78a4782a8c1f401850eded155697eb488c3cf52985844f4cbe73","cb837951c7cf794c2e5f38b246335a2ba8c71e35c6649eb78855bbe57c6b977d","cd3e47a7925f0390fd04245a50635830f193aa3b266ad3e5375013c674b5bcd8","d662a71707c57140fdf514569a0f75da6823f428de0b17a2afdf475d31e15303","dbaad8c7c13344f64c27d499080474e49f6ec132aec73acc96f0ac0d3f2e3e16","dd6a629b57ea60ba57251efddbbbdb4d2c2e82f499eab669ea14090486080d3a","e3f8f74f4ac7974d5d26419976cf2a9ba9eb4c6305ea19eb004a8f99878158e1","e90ed5180fdd13ae6dc7202a6c4d372d43971dc2fbb87cbe011c4ac077efd051","f690b95058cfa71c983ace20326b36814a04481485faf504794072488bf864fc"],"recordQualifiers":{},"scopeLabel":"ORPHA:79086","sourceIds":["ORPHA:79086"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-3ed1f8a000d5d8991015"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0011025","HP:0003119","HP:0005339","HP:0000956","HP:0005616","HP:0001735","HP:0009592"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":28,"sourceGroups":{"orphanet":28}},"features":[{"hpoId":"HP:0011025","label":"Abnormal cardiovascular system physiology","primary":true},{"hpoId":"HP:0003119","label":"Abnormal circulating lipid concentration","primary":true},{"hpoId":"HP:0005339","label":"Abnormality of complement system","primary":true},{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":true},{"hpoId":"HP:0005616","label":"Accelerated skeletal maturation","primary":true},{"hpoId":"HP:0001735","label":"Acute pancreatitis","primary":true},{"hpoId":"HP:0009592","label":"Astrocytoma","primary":true},{"hpoId":"HP:0002960","label":"Autoimmunity","primary":false},{"hpoId":"HP:0003707","label":"Calf muscle pseudohypertrophy","primary":false},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":false},{"hpoId":"HP:0001394","label":"Cirrhosis","primary":false},{"hpoId":"HP:0002230","label":"Generalized hirsutism","primary":false},{"hpoId":"HP:0007440","label":"Generalized hyperpigmentation","primary":false},{"hpoId":"HP:0009064","label":"Generalized lipodystrophy","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0000842","label":"Hyperinsulinemia","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000831","label":"Insulin-resistant diabetes mellitus","primary":false},{"hpoId":"HP:0002665","label":"Lymphoma","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0012490","label":"Panniculitis","primary":false},{"hpoId":"HP:0000147","label":"Polycystic ovaries","primary":false},{"hpoId":"HP:0005328","label":"Progeroid facial appearance","primary":false},{"hpoId":"HP:0000093","label":"Proteinuria","primary":false},{"hpoId":"HP:0012064","label":"Unicameral bone cyst","primary":false}],"ledeHtml":"A rare lipodystrophic syndrome characterized by loss of adipose tissue, and is a syndrome of insulin resistance that leads to increased cardiovascular risk. Acquired generalized lipodystrophy is related to a selective loss of subcutaneous adipose tissue occurring exclusively at the extremities (face, legs, arms, palms and sometimes soles).","mondoId":"MONDO:0019193","node":{"canonicalSlug":"acquired-generalized-lipodystrophy","comparisons":[{"documentSha256":"07458c44689152267f1474d8f25159857ffb64ab39073ac00b987c18f68ee388","key":"legacy-acquired-lipodystrophy","kind":"legacy","label":"acquired lipodystrophy","memberIds":["MONDO:0012104","MONDO:0019193","MONDO:0020089"],"mondoId":"MONDO:0020089","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/acquired-lipodystrophy.07458c44689152267f1474d8f25159857ffb64ab39073ac00b987c18f68ee388.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Acquired generalized lipodystrophy","originalSourceId":"ORPHA:79086","paragraphs":["A rare lipodystrophic syndrome characterized by loss of adipose tissue, and is a syndrome of insulin resistance that leads to increased cardiovascular risk. Acquired generalized lipodystrophy is related to a selective loss of subcutaneous adipose tissue occurring exclusively at the extremities (face, legs, arms, palms and sometimes soles)."],"rawAttribution":"MONDO:0019193","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:40Z","upstream":"MONDO:0019193","url":"https://rarediseases.info.nih.gov/diseases/12603"},"ownColumnKeys":["population-3ed1f8a000d5d8991015"],"publication":"published","relationships":[{"kind":"parent","label":"acquired lipodystrophy","mondoId":"MONDO:0020089","slug":"acquired-lipodystrophy"},{"kind":"parent","label":"generalized lipodystrophy","mondoId":"MONDO:0027766","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0928c654a979a6875d8f3e1556f89a1a8e2b4b6370343ee6812ba88b51592786","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001394","is_excluded":false,"label":"Cirrhosis","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0a97ce97fc2b50c4b7e70615d1f4f8ed15e215ccdc1ed0db938aaca271930d28","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0dfbeb03c6b16df44666c7cb5af727fc3ab44693f90dcb9a9e988a9bd28f2bc1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0012064","is_excluded":false,"label":"Unicameral bone cyst","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0e8dc948e7d635e9ca37b79c7a23081a65db67c4399945985bb6951a5c6e56b7","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005339","is_excluded":false,"label":"Abnormality of complement system","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1935c6cb733a8ab6b3a16bfcd4541a9335c54e53ebdd2f197805a7abd4a5a312","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002665","is_excluded":false,"label":"Lymphoma","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"30024c96a2c3c16608d0337e5549093146826a5b92e685ddd07455f69b31a2fe","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003707","is_excluded":false,"label":"Calf muscle pseudohypertrophy","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4753473b68d328c835c966fc40957564ad005d5b8e7a13dcbfb3048167072ebb","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002960","is_excluded":false,"label":"Autoimmunity","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4811325d6fc584141fa12679ec7b72273ded7cc294adf3bd3a79b9e9b0364170","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001735","is_excluded":false,"label":"Acute pancreatitis","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c4e29e9de9619eb3ff85b8eca777c8d63c9abdb4b1a396ae283ed6d18558a1c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5ec7be299a25c5031c9da719591999420ba8f41208c18885c439ce4b541f358c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"63503c966187ef073a282efe75f440f52b006d62f89fdba59d492544b2003123","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6fcc62aad29f45ff5c7a21b25047c54f7bc169a4094974c02d7f9d4bd6c2e97a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7ff1183729d2a3114bd5e943af5c60984679a952ae3d6a494926b3c733cbce4d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"809e359603b6e5d4894b7662bd5bdace0d65151456b9ecffcf17fd6443ccf3b2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0009592","is_excluded":false,"label":"Astrocytoma","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"894afe34c81524427588d9d3bdc9072ebca4b335c8b74d22d7695e3104494171","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005616","is_excluded":false,"label":"Accelerated skeletal maturation","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9da8ea84d8eba5670a5e29f76a1a154dca037458871d1d37cee6930f8a557e66","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002230","is_excluded":false,"label":"Generalized hirsutism","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a4d929869b0aa27bc53fbb19ab4e2fb11b0a488bfd470a0bf9429e3b6270083e","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a5535c58b8c517467712c1fcf8807cb72fe3c435c712ccac9d5365af1d0e5199","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005328","is_excluded":false,"label":"Progeroid facial appearance","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b22ac21dc15feb43c9e8ba378a25065fa4b15967b1b736790a429cdf7d8288b2","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000842","is_excluded":false,"label":"Hyperinsulinemia","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b5c74f3b11bf78a4782a8c1f401850eded155697eb488c3cf52985844f4cbe73","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb837951c7cf794c2e5f38b246335a2ba8c71e35c6649eb78855bbe57c6b977d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cd3e47a7925f0390fd04245a50635830f193aa3b266ad3e5375013c674b5bcd8","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007440","is_excluded":false,"label":"Generalized hyperpigmentation","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d662a71707c57140fdf514569a0f75da6823f428de0b17a2afdf475d31e15303","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0009064","is_excluded":false,"label":"Generalized lipodystrophy","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dbaad8c7c13344f64c27d499080474e49f6ec132aec73acc96f0ac0d3f2e3e16","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dd6a629b57ea60ba57251efddbbbdb4d2c2e82f499eab669ea14090486080d3a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012490","is_excluded":false,"label":"Panniculitis","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e3f8f74f4ac7974d5d26419976cf2a9ba9eb4c6305ea19eb004a8f99878158e1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003119","is_excluded":false,"label":"Abnormal circulating lipid concentration","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e90ed5180fdd13ae6dc7202a6c4d372d43971dc2fbb87cbe011c4ac077efd051","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011025","is_excluded":false,"label":"Abnormal cardiovascular system physiology","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f690b95058cfa71c983ace20326b36814a04481485faf504794072488bf864fc","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79086","disease_name":"Acquired generalized lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000093","is_excluded":false,"label":"Proteinuria","onset_id":null,"reference":"ORPHA:79086","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12603\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019193\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0019193</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare lipodystrophic syndrome characterized by loss of adipose tissue, and is a syndrome of insulin resistance that leads to increased cardiovascular risk. Acquired generalized lipodystrophy is related to a selective loss of subcutaneous adipose tissue occurring exclusively at the extremities (face, legs, arms, palms and sometimes soles).</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12603\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"acquired-generalized-lipodystrophy","sourceDocuments":[{"name":"GARD: Acquired generalized lipodystrophy","reviewed":null,"source_release":"2026-10-25T03:41:40Z","url":"https://rarediseases.info.nih.gov/diseases/12603"},{"name":"MONDO: acquired generalized lipodystrophy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0019193"}],"sourceNote":"","synonyms":["acquired generalized lipodystrophy","acquired lipoatrophic diabetes","Lawrence syndrome","Lawrence-Seip syndrome"],"takeawayHtml":"","title":"acquired generalized lipodystrophy"},"schemaVersion":1}
